Brief: Aura Biosciences Q2 Operating Expenses USD 22.762 Million
08/08/2024 12:00
Aug 08 (Reuters) - Aura Biosciences Q2 net income USD -20.337 million. * Q2 operating income USD -22.762 million
Recent news on Aura Biosciences
See all newsBrief: Aura Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Aura Biosciences - May Offer Securities Up To $500 Million Aggregate
Brief: Aura Biosciences Reports Second Quarter 2026 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Aecom, Humana, Mosaic
Aura Biosciences Q1 net loss widens on higher R&D costs